Thomas M Annesley

4.9k total citations · 1 hit paper
99 papers, 3.7k citations indexed

About

Thomas M Annesley is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Thomas M Annesley has authored 99 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Pediatrics, Perinatology and Child Health and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Thomas M Annesley's work include Pharmacological Effects and Toxicity Studies (14 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Renal Transplantation Outcomes and Treatments (9 papers). Thomas M Annesley is often cited by papers focused on Pharmacological Effects and Toxicity Studies (14 papers), Cardiac electrophysiology and arrhythmias (10 papers) and Renal Transplantation Outcomes and Treatments (9 papers). Thomas M Annesley collaborates with scholars based in United States, United Kingdom and Germany. Thomas M Annesley's co-authors include Charles N. Ellis, James B. Walker, Peter A. Ward, Gerd O. Till, John J. Voorhees, J. Robert Hatherill, Robin G. Kunkel, Ted Hamilton, Michael de Buitleir and Eric J. Duell and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Thomas M Annesley

92 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ion Suppression in Mass Spectrometry

2003 1.3k citations Thomas M Annesley Clinical Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas M Annesley United States	25	987	647	461	389	388	99	3.7k
Katharina Rentsch Switzerland	46	1.4k 1.4×	384 0.6×	546 1.2×	199 0.5×	504 1.3×	186	6.3k
Uta Ceglarek Germany	42	2.1k 2.1×	810 1.3×	184 0.4×	348 0.9×	230 0.6×	200	5.3k
Kamal K. Midha Canada	29	1.1k 1.1×	771 1.2×	894 1.9×	550 1.4×	622 1.6×	75	5.2k
Saı̈k Urien France	43	1.4k 1.4×	229 0.4×	692 1.5×	307 0.8×	1.1k 2.9×	283	6.2k
Momir Mikov Serbia	39	1.4k 1.5×	199 0.3×	660 1.4×	142 0.4×	273 0.7×	263	5.1k
Werner Siegmund Germany	42	1.1k 1.1×	366 0.6×	560 1.2×	156 0.4×	1.5k 4.0×	185	6.3k
D. Seidel Germany	53	1.8k 1.8×	226 0.3×	337 0.7×	970 2.5×	291 0.8×	244	9.6k
Matti J. Tikkanen Finland	48	1.3k 1.3×	115 0.2×	297 0.6×	326 0.8×	298 0.8×	226	8.1k
John T. Slattery United States	45	1.1k 1.1×	132 0.2×	678 1.5×	395 1.0×	951 2.5×	132	6.9k
Nariyasu Mano Japan	31	1.4k 1.4×	589 0.9×	312 0.7×	101 0.3×	448 1.2×	300	4.2k

Countries citing papers authored by Thomas M Annesley

Since Specialization

Citations

This map shows the geographic impact of Thomas M Annesley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M Annesley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M Annesley more than expected).

Fields of papers citing papers by Thomas M Annesley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M Annesley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M Annesley. The network helps show where Thomas M Annesley may publish in the future.

Co-authorship network of co-authors of Thomas M Annesley

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M Annesley. A scholar is included among the top collaborators of Thomas M Annesley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M Annesley. Thomas M Annesley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stuckey, Linda J., et al.. (2013). Mycophenolic Acid Pharmacokinetics in Lung Transplant Recipients With Cystic Fibrosis. Therapeutic Drug Monitoring. 36(2). 148–151. 7 indexed citations

Annesley, Thomas M, et al.. (2005). Quantification of Mycophenolic Acid and Glucuronide Metabolite in Human Serum by HPLC-Tandem Mass Spectrometry. Clinical Chemistry. 51(5). 872–877. 45 indexed citations

Tankanow, Roberta M., Daniel S. Streetman, Scott Smith, et al.. (2003). Interaction Study between Digoxin and a Preparation of Hawthorn (Crataegus oxyacantha). The Journal of Clinical Pharmacology. 43(6). 637–642. 45 indexed citations

Roberts, William L., et al.. (2001). Performance Characteristics of Four Free Phenytoin Immunoassays. Therapeutic Drug Monitoring. 23(2). 148–154. 10 indexed citations

Judd, W. J. & Thomas M Annesley. (1996). The acquired-B phenomenon. Transfusion Medicine Reviews. 10(2). 111–117. 8 indexed citations

Oellerich, Michael, Victor W. Armstrong, B D Kahan, et al.. (1995). Lake Louise Consensus Conference on Cyclosporin Monitoring in Organ Transplantation: Report of the Consensus Panel. Therapeutic Drug Monitoring. 17(6). 642–654. 205 indexed citations

Li, Yi‐Ju, Thomas M Annesley, Bruce Kaplan, & Kenneth L. Brayman. (1995). Analytic Requirements for Immunosuppressive Drugs in Clinical Trials. Therapeutic Drug Monitoring. 17(6). 577–583. 22 indexed citations

Annesley, Thomas M, et al.. (1994). Determination of Felbamate in Human Serum by High-Performance Liquid Chromatography. Therapeutic Drug Monitoring. 16(4). 419–424. 12 indexed citations

Turgeon, D. Kim, Alan B. Leichtman, Robert Schmouder, et al.. (1994). PREDICTION OF INTERPATIENT AND INTRAPATIENT VARIATION IN OG 37–325 DOSING REQUIREMENTS BY THE ERYTHROMYCIN BREATH TEST. Transplantation. 57(12). 1736–1741. 19 indexed citations

10.

Annesley, Thomas M, et al.. (1991). Liquid chromatographic analysis of mexiletine in serum, with alternate application to tocainide, procainamide, and N‐acetylprocainamide. Biomedical Chromatography. 5(1). 19–22. 3 indexed citations

11.

Schramm, Willfried, et al.. (1991). Measurement of Phenytoin and Carbamazepine in an Ultrafiltrate of Saliva. Therapeutic Drug Monitoring. 13(5). 452–460. 17 indexed citations

12.

Bleske, Barry E., et al.. (1990). The Effect of Ciprofloxacin on the Pharmacokinetic and ECG Parameters of Quinidine. The Journal of Clinical Pharmacology. 30(10). 911–915. 4 indexed citations

13.

Watkins, Paul B., Ted Hamilton, Thomas M Annesley, et al.. (1990). The erythromycin breath test as a predictor of cyclosporine blood levels. Clinical Pharmacology & Therapeutics. 48(2). 120–129. 84 indexed citations

14.

Taylor, Robert S., Charles N. Ellis, Norman D. Weiner, et al.. (1988). Topical Ciclosporin for Psoriasis: In vitro Skin Penetration and Clinical Study. Skin Pharmacology and Physiology. 1(4). 246–249. 40 indexed citations

15.

Kou, William H., et al.. (1988). Significance of ST segment depression during paroxysmal supraventricular tachycardia. Journal of the American College of Cardiology. 12(2). 383–387. 26 indexed citations

16.

Fisher, Gary J., Eric J. Duell, Brian J. Nickoloff, et al.. (1988). Levels of Cyclosporin in Epidermis of Treated Psoriasis Patients Differentially Inhibit Growth of Keratinocytes Cultured in Serum Free Versus Serum Containing Media. Journal of Investigative Dermatology. 91(2). 142–146. 94 indexed citations

17.

Morady, Fred, et al.. (1988). Pharmacodynamics of intravenous procainamide as used during acute electropharmacologic testing. The American Journal of Cardiology. 61(1). 93–98. 8 indexed citations

18.

Morady, Fred, Lorenzo A. DiCarlo, Ryszard B. Król, et al.. (1987). Role of myocardial ischemia during programmed stimulation in survivors of cardiac arrest with coronary artery disease. Journal of the American College of Cardiology. 9(5). 1004–1012. 37 indexed citations

19.

DiCarlo, Lorenzo A., et al.. (1986). Effects of magnesium sulfate on cardiac conduction and refractoriness in humans. Journal of the American College of Cardiology. 7(6). 1356–1362. 122 indexed citations

20.

Annesley, Thomas M, Mary F. Burritt, & Robert A. Kyle. (1982). Artifactual Hypercalcemia in Multiple Myeloma. Mayo Clinic Proceedings. 57(9). 572–575. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact